ArticleBiomolecules & biomedicine2026
Astaxanthin attenuates bisphenol A-induced testicular toxicity in Wistar rats by reducing apoptosis and fibrosis via Bax/Bcl-2 balance and collagen gene expression.
Article in Biomolecules & biomedicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bisphenol A (BPA), a synthetic compound widely used in plastic manufacturing, has been shown to cause testicular damage and disrupt spermatogenesis. This study aimed to investigate the potential protective effects of astaxanthin (AST) against BPA-induced testicular injury. Four experimental groups of Wistar Albino rats were established (n=8 per group): Control, Sham, BPA, and BPA+AST. At the conclusion of the study, serum samples were analyzed for total antioxidant capacity (TAC), total oxidant status (TOS), oxidative stress index (OSI) [OSI=TOS/TAC], and CRP. Histopathological evaluations included measurements of tubule diameter, Johnsen scoring, and Masson's trichrome staining. The expression levels of anti-B-cell lymphoma 2 (Bcl-2) and anti-Bcl-2-associated X protein (Bax) were assessed using immunofluorescence (IF) staining and RT-qPCR in testicular tissues. Additionally, tissue collagen (COL1A1, COL3A1) expressions were quantified via RT-qPCR. Results indicated significant increases in TOS, OSI, and CRP levels in the BPA group (p<0.001, p<0.001, and p=0.042, respectively), while TAC levels remained unchanged (p=0.119). AST administration did not significantly alter these biochemical parameters. Histopathological analysis revealed decreased Johnsen scores and tubule diameters in the BPA group; however, these metrics improved in the BPA+AST group. IF analysis confirmed that AST restored the pro-apoptotic Bax/Bcl-2 imbalance induced by BPA (p<0.001), although RT-qPCR results indicated that AST normalized only Bax expression (p<0.001) while Bcl-2 levels remained unchanged (p=0.487). Moreover, COL1A1 and COL3A1 were significantly upregulated in the BPA group (p<0.001 for both), and Masson's trichrome staining corroborated the presence of fibrosis in this group. AST treatment mitigated these fibrotic changes, as evidenced by reductions in gene expression (p=0.001 for COL1A1 and p=0.005 for COL3A1) and improvements in Masson's trichrome staining. In conclusion, this study suggests that AST may confer a protective effect against BPA-induced testicular damage by reducing apoptosis and fibrosis; however, changes in oxidative stress markers did not achieve statistical significance. Furthermore, AST may enhance spermatogenesis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.